RESEARCH TRIANGLE PARK, N.C. and SAN JOSE, Calif., Sept. 13, 2023 /PRNewswire/ -- Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and ...
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2025 /PRNewswire/ -- Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological ...
RESEARCH TRIANGLE PARK, N.C., June 12, 2025 /PRNewswire/ -- Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for ...
A mix good news, bad news for Triangle biotechs: Dignify Therapeutics has secured $4.1 million in new funding from the National Institutes of Health. But Novan Therapeutics is mulling next steps after ...
RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Howard Palefsky and Dr.
Dignify Therapeutics, an early stage drug developer, joined the Blackstone Entrepreneurs Network (BEN), giving the small company access to a wide network of other life-sciences entrepreneurs. Dignify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results